Finance and Economic

Sigma-Aldrich Corp. said Wednesday that it is expanding a research facility in Cambridge, England, to serve drug development customers in Europe, the United States and the Asia-Pacific region.

The St. Louis-based company said it is adding 7,500 square feet of laboratory capacity to the facility, and reorganizing offices to accommodate the installation later this year of state-of-the-art spectroscopic and diffraction equipment.

It is the second phase in a multi-step development program that in total will cost $600,000.

Sourse